Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02602795 · ClinicalTrials.gov registry record · NA
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
A NA study of HIV and Sexually Transmitted Diseases, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02602795: Completed NA study of HIV and Sexually Transmitted Diseases, sponsored by Rhode Island Hospital.
NCT02602795 is a NA study of HIV and Sexually Transmitted Diseases that has completed, run by Rhode Island Hospital. The registered enrollment target is 14 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02602795, a NA study of HIV and Sexually Transmitted Diseases, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Before starting treatment with XR-NTX, a medication that blocks the positive effects of opioids and helps people stay off opioids, individuals who are dependent on opioids first have to endure a difficult withdrawal process. This study aims to develop and test an intervention to help people who are opioid dependent successfully complete that transition; the investigators will also develop and test a comparison condition aimed at reducing HIV risk behavior.
Primary Outcome
The investigators will compare the odds of successful detoxification, or receipt of the first XR-NTX injection, between treatment groups.
Conditions Studied
Interventions
- BEHAVIORAL Acceptance and Commitment Therapy
- BEHAVIORAL Information Motivation Behavioral Model
Study Locations (1)
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-12 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT02602795 record still lists
NCT02602795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Acceptance and Commitment Therapy is the first listed.
NCT02602795 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT02602795 about?
NCT02602795 is a clinical study titled "Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence". Before starting treatment with XR-NTX, a medication that blocks the positive effects of opioids and helps people stay off opioids, individuals who are dependent on opioids first have to endure a difficult withdrawal process. This study aims to develop and test an intervention to help people who are ...
What is the current status of trial NCT02602795?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2015-12. Estimated completion is 2018-06.
What conditions does trial NCT02602795 study?
This clinical trial studies the following conditions: HIV, Sexually Transmitted Diseases, Opiate Dependence.
What interventions are being tested in trial NCT02602795?
The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL), Information Motivation Behavioral Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT02602795?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02602795 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02602795's enrollment target sits among peer trials
14 290th of 303 higher than 12 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia